Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategyAndrew W. Bradbury, Gillian Raab, F. Gerry R. Fowkes et al.|Journal of Vascular Surgery|2010Cited by 581
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment receivedAndrew W. Bradbury, Gillian Raab, Jocelyn Bell et al.|Journal of Vascular Surgery|2010Cited by 358
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision makingAndrew W. Bradbury, Gillian Raab, Donald J. Adam et al.|Journal of Vascular Surgery|2010Cited by 246
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysisJohn Forbes, Andrew W. Bradbury, Donald J. Adam et al.|Journal of Vascular Surgery|2010Cited by 130
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classificationAndrew W. Bradbury, Gillian Raab, Ian Gillespie et al.|Journal of Vascular Surgery|2010Cited by 69